CJC-1295 No DAC + Ipamorelin – Lyophilized Peptide Blend
This research blend combines CJC-1295 No DAC (Modified GRF 1-29), a short-acting growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS-R1a / ghrelin-receptor agonist). The two are frequently studied together as a complementary GHRH + GHRP model for stimulating pulsatile growth hormone (GH) release in research settings.
Research Applications
- GHRH + GHRP synergy and pulsatile GH-release research
- GHS-R1a (ghrelin receptor) signaling studies
- Pituitary GH-secretion and endocrine pathway models
For background, see our CJC-1295 research guide.
Product Details
- Compounds: CJC-1295 No DAC (Mod GRF 1-29) + Ipamorelin
- Purity: >98% (HPLC verified)
- Form: Lyophilized powder
- Storage: Store at -20°C; after reconstitution, refrigerate at 2–8°C.
Why Buy CJC-1295 No DAC + Ipamorelin From MyGLP1Store
Veteran-owned, U.S.-based supplier. Third-party lab tested with a published Certificate of Analysis (COA), documented purity, and same-day domestic shipping. Verified Trustpilot 4.8.
Research References
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561. PubMed
- Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799–805. Link
- Ionescu M, Frohman LA. Pulsatile secretion of GH persists during continuous stimulation by CJC-1295, a long-acting GHRH analog. J Clin Endocrinol Metab. 2006;91(12):4792–4797. PubMed
For laboratory and research use only. Not for human or veterinary consumption. Nothing here is medical advice or a dosing recommendation.








Reviews
There are no reviews yet.